LEUKEMIA AND LYMPHOMA RISKS DERIVED FROM SOLVENTS

被引：0
|
作者：
BRANDT, L
机构：
来源：
MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY | 1987年 / 4卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 205
页数：7
相关论文
共 50 条
  • [1] LEUKEMIA DERIVED FROM INTERMEDIATELY DIFFERENTIATED LYMPHOCYTIC LYMPHOMA
    BERGMANN, L
    HOELZER, D
    PATHOLOGY RESEARCH AND PRACTICE, 1988, 183 (01) : 63 - 64
  • [2] DIAGNOSTIC INFORMATION DERIVED FROM IMMUNOTYPING 1000 PATIENTS WITH LEUKEMIA AND LYMPHOMA
    JOSE, DG
    PILKINGTON, GR
    WOLF, MM
    DING, JC
    VANDERWEYDEN, MB
    GAN, TE
    ELLIOTT, P
    WHITESIDE, M
    PATHOLOGY, 1983, 15 (01) : 53 - 60
  • [3] EFFECT OF ASPARAGINASE ON CELL LINES DERIVED FROM CHILDREN WITH ACUTE LEUKEMIA AND LYMPHOMA
    LAZARUS, H
    MCCOY, TA
    FARBER, S
    FOLEY, GE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1968, 9 (MAR): : 40 - &
  • [4] Solvents derived from biomass and their potential as green solvents
    Lomba, Laura
    Zuriaga, Estefania
    Giner, Beatriz
    CURRENT OPINION IN GREEN AND SUSTAINABLE CHEMISTRY, 2019, 18 : 51 - 56
  • [5] LEUKEMIA RISKS FROM NEUTRONS - REPLY
    ROSSI, HH
    MAYS, CW
    HEALTH PHYSICS, 1979, 36 (03): : 466 - 466
  • [6] CANCER RISKS DERIVED FROM ALCOHOL
    TUYNS, AJ
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1987, 4 (3-4): : 241 - 244
  • [7] CHARACTERIZATION OF CELL-LINES DERIVED FROM ADULT T-CELL LEUKEMIA AND LYMPHOMA (ATL)
    HARADA, T
    NAGASAKI, M
    KATOH, T
    INOUE, K
    KUBOTA, H
    MORIKAWA, S
    JOURNAL OF LEUKOCYTE BIOLOGY, 1984, 36 (02) : 235 - 236
  • [8] Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma
    Lucas, David M.
    Still, Patrick C.
    Perez, Lynette Bueno
    Grever, Michael R.
    Kinghorn, A. Douglas
    CURRENT DRUG TARGETS, 2010, 11 (07) : 812 - 822
  • [9] Risks of non Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications
    Doody, MM
    Linet, MS
    Glass, AG
    Rochelle, RE
    Pottern, LM
    Rush, BB
    Boice, JD
    Fraumeni, JF
    Friedman, GD
    EPIDEMIOLOGY, 1996, 7 (02) : 131 - 139
  • [10] Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma Subtype
    Morton, Lindsay M.
    Curtis, Rochelle E.
    Linet, Martha S.
    Bluhm, Elizabeth C.
    Tucker, Margaret A.
    Caporaso, Neil
    Ries, Lynn A. G.
    Fraumeni, Joseph F., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : 4935 - 4944
12345